Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
US9801923B2 · kind B2 · utility
0Cited by
10References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 29, 2017 |
| Grant date | Oct 31, 2017 |
| Priority date | — |
| Expiry date | May 29, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/21
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Fusion proteins comprising cytokines, particularly insulin-like growth factor-1 (IGF-1) and variants thereof, epidermal growth factor (EGF), and other ligands to the EGF receptor, are provided. The fusion proteins further comprise SEQ ID NO:1 or other segments having lysine, glutamic acid, or aspartic acid residues. Uses for the fusion proteins are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.